$GEHC (+0.4% pre) GE HealthCare Technologies Non-GAAP EPS of $1.14 beats by $0.09, revenue of $4.86B misses by $10M - SA https://t.co/btjH9rFlkB
$HES (+0.9% pre) Hess Non-GAAP EPS of $2.14 beats by $0.37, revenue of $3.2B beats by $160M - SA https://t.co/CLGCwasF3j
$GEHC (-80.4% pre) GE HealthCare Technologies Non-GAAP EPS of $1.14 beats by $0.09, revenue of $4.86B misses by $10M - SA https://t.co/w7agXN4GkX
GE HealthCare reported its third quarter 2024 financial results, showing a mixed performance. The company beat Wall Street estimates on earnings per share (EPS), reporting a Non-GAAP EPS of $1.14, which exceeded expectations by $0.09. However, it missed revenue expectations, reporting $4.86 billion, which was $10 million short of forecasts. Despite the revenue miss, the company's stock rose as U.S. medical device demand offset a slowdown in the Chinese market. GE HealthCare also raised its annual earnings guidance, although it noted that full-year organic revenue growth is now trending towards the lower end of the previously expected 1-2% range due to continued softness in the China market. The stock showed a pre-market change of +0.4%.
